 | • レポートコード：QYR2104Z0839 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、バイオレーションのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（植物、情報化学物質）、用途別市場規模（シリアル・穀物、果物・野菜）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオレーションの市場動向 ・企業の競争状況、市場シェア ・バイオレーションの種類別市場規模（植物、情報化学物質） ・バイオレーションの用途別市場規模（シリアル・穀物、果物・野菜） ・バイオレーションの北米市場規模2016-2027（アメリカ、カナダ） ・バイオレーションのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオレーションのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオレーションの中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオレーションの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agralan Ltd.、BASF SE.、Bayer AG、Gowan Company、Inora、Isagro Spa、Koppert BV、McLaughlin Gormley King (MGK)、Rentokil Initial Plc、Russell IPM Ltd.、Summit Chemical、Suterra） ・結論 |
Biorational represents materials that are relatively non-toxic to people with few environmental side-effects, and is widely used in Pest control area.
North America dominated the biorationals industry in 2017. The market size is anticipated to grow at a CAGR of over 10% over the forecast period. Stringent regulatory framework against the synthetic pesticides has contributed tremendously towards market penetration in the region. Various agri-business initiatives were adopted by the food processors and farming enterprises to cater the growing concerns towards food security. Ongoing industrialization of the food system, particularly in the U.S. and Canada is anticipated to drive investments for enhancing crop yield rates, with minimal environmental impact.
Market Analysis and Insights: Global Biorationals Market
The global Biorationals market size is projected to reach US$ 3915.9 million by 2026, from US$ 1270.6 million in 2019, at a CAGR of 17.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biorationals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biorationals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biorationals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biorationals market.
Global Biorationals Scope and Market Size
Biorationals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biorationals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Botanical
Semiochemicals
Segment by Application
Cereals & Grains
Fruits & Vegetables
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agralan Ltd.
BASF SE.
Bayer AG
Gowan Company
Inora
Isagro Spa
Koppert BV
McLaughlin Gormley King (MGK)
Rentokil Initial Plc
Gowan Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biorationals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Botanical
1.2.3 Semiochemicals
1.3 Market by Application
1.3.1 Global Biorationals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cereals & Grains
1.3.3 Fruits & Vegetables
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biorationals Market Perspective (2016-2027)
2.2 Biorationals Growth Trends by Regions
2.2.1 Biorationals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biorationals Historic Market Share by Regions (2016-2021)
2.2.3 Biorationals Forecasted Market Size by Regions (2022-2027)
2.3 Biorationals Industry Dynamic
2.3.1 Biorationals Market Trends
2.3.2 Biorationals Market Drivers
2.3.3 Biorationals Market Challenges
2.3.4 Biorationals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biorationals Players by Revenue
3.1.1 Global Top Biorationals Players by Revenue (2016-2021)
3.1.2 Global Biorationals Revenue Market Share by Players (2016-2021)
3.2 Global Biorationals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biorationals Revenue
3.4 Global Biorationals Market Concentration Ratio
3.4.1 Global Biorationals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biorationals Revenue in 2020
3.5 Biorationals Key Players Head office and Area Served
3.6 Key Players Biorationals Product Solution and Service
3.7 Date of Enter into Biorationals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biorationals Breakdown Data by Type
4.1 Global Biorationals Historic Market Size by Type (2016-2021)
4.2 Global Biorationals Forecasted Market Size by Type (2022-2027)
5 Biorationals Breakdown Data by Application
5.1 Global Biorationals Historic Market Size by Application (2016-2021)
5.2 Global Biorationals Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biorationals Market Size (2016-2027)
6.2 North America Biorationals Market Size by Type
6.2.1 North America Biorationals Market Size by Type (2016-2021)
6.2.2 North America Biorationals Market Size by Type (2022-2027)
6.2.3 North America Biorationals Market Size by Type (2016-2027)
6.3 North America Biorationals Market Size by Application
6.3.1 North America Biorationals Market Size by Application (2016-2021)
6.3.2 North America Biorationals Market Size by Application (2022-2027)
6.3.3 North America Biorationals Market Size by Application (2016-2027)
6.4 North America Biorationals Market Size by Country
6.4.1 North America Biorationals Market Size by Country (2016-2021)
6.4.2 North America Biorationals Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biorationals Market Size (2016-2027)
7.2 Europe Biorationals Market Size by Type
7.2.1 Europe Biorationals Market Size by Type (2016-2021)
7.2.2 Europe Biorationals Market Size by Type (2022-2027)
7.2.3 Europe Biorationals Market Size by Type (2016-2027)
7.3 Europe Biorationals Market Size by Application
7.3.1 Europe Biorationals Market Size by Application (2016-2021)
7.3.2 Europe Biorationals Market Size by Application (2022-2027)
7.3.3 Europe Biorationals Market Size by Application (2016-2027)
7.4 Europe Biorationals Market Size by Country
7.4.1 Europe Biorationals Market Size by Country (2016-2021)
7.4.2 Europe Biorationals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biorationals Market Size (2016-2027)
8.2 Asia-Pacific Biorationals Market Size by Type
8.2.1 Asia-Pacific Biorationals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biorationals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biorationals Market Size by Type (2016-2027)
8.3 Asia-Pacific Biorationals Market Size by Application
8.3.1 Asia-Pacific Biorationals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biorationals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biorationals Market Size by Application (2016-2027)
8.4 Asia-Pacific Biorationals Market Size by Region
8.4.1 Asia-Pacific Biorationals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biorationals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biorationals Market Size (2016-2027)
9.2 Latin America Biorationals Market Size by Type
9.2.1 Latin America Biorationals Market Size by Type (2016-2021)
9.2.2 Latin America Biorationals Market Size by Type (2022-2027)
9.2.3 Latin America Biorationals Market Size by Type (2016-2027)
9.3 Latin America Biorationals Market Size by Application
9.3.1 Latin America Biorationals Market Size by Application (2016-2021)
9.3.2 Latin America Biorationals Market Size by Application (2022-2027)
9.3.3 Latin America Biorationals Market Size by Application (2016-2027)
9.4 Latin America Biorationals Market Size by Country
9.4.1 Latin America Biorationals Market Size by Country (2016-2021)
9.4.2 Latin America Biorationals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biorationals Market Size (2016-2027)
10.2 Middle East & Africa Biorationals Market Size by Type
10.2.1 Middle East & Africa Biorationals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biorationals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biorationals Market Size by Type (2016-2027)
10.3 Middle East & Africa Biorationals Market Size by Application
10.3.1 Middle East & Africa Biorationals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biorationals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biorationals Market Size by Application (2016-2027)
10.4 Middle East & Africa Biorationals Market Size by Country
10.4.1 Middle East & Africa Biorationals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biorationals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agralan Ltd.
11.1.1 Agralan Ltd. Company Details
11.1.2 Agralan Ltd. Business Overview
11.1.3 Agralan Ltd. Biorationals Introduction
11.1.4 Agralan Ltd. Revenue in Biorationals Business (2016-2021)
11.1.5 Agralan Ltd. Recent Development
11.2 BASF SE.
11.2.1 BASF SE. Company Details
11.2.2 BASF SE. Business Overview
11.2.3 BASF SE. Biorationals Introduction
11.2.4 BASF SE. Revenue in Biorationals Business (2016-2021)
11.2.5 BASF SE. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Biorationals Introduction
11.3.4 Bayer AG Revenue in Biorationals Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Gowan Company
11.4.1 Gowan Company Company Details
11.4.2 Gowan Company Business Overview
11.4.3 Gowan Company Biorationals Introduction
11.4.4 Gowan Company Revenue in Biorationals Business (2016-2021)
11.4.5 Gowan Company Recent Development
11.5 Inora
11.5.1 Inora Company Details
11.5.2 Inora Business Overview
11.5.3 Inora Biorationals Introduction
11.5.4 Inora Revenue in Biorationals Business (2016-2021)
11.5.5 Inora Recent Development
11.6 Isagro Spa
11.6.1 Isagro Spa Company Details
11.6.2 Isagro Spa Business Overview
11.6.3 Isagro Spa Biorationals Introduction
11.6.4 Isagro Spa Revenue in Biorationals Business (2016-2021)
11.6.5 Isagro Spa Recent Development
11.7 Koppert BV
11.7.1 Koppert BV Company Details
11.7.2 Koppert BV Business Overview
11.7.3 Koppert BV Biorationals Introduction
11.7.4 Koppert BV Revenue in Biorationals Business (2016-2021)
11.7.5 Koppert BV Recent Development
11.8 McLaughlin Gormley King (MGK)
11.8.1 McLaughlin Gormley King (MGK) Company Details
11.8.2 McLaughlin Gormley King (MGK) Business Overview
11.8.3 McLaughlin Gormley King (MGK) Biorationals Introduction
11.8.4 McLaughlin Gormley King (MGK) Revenue in Biorationals Business (2016-2021)
11.8.5 McLaughlin Gormley King (MGK) Recent Development
11.9 Rentokil Initial Plc
11.9.1 Rentokil Initial Plc Company Details
11.9.2 Rentokil Initial Plc Business Overview
11.9.3 Rentokil Initial Plc Biorationals Introduction
11.9.4 Rentokil Initial Plc Revenue in Biorationals Business (2016-2021)
11.9.5 Rentokil Initial Plc Recent Development
11.10 Russell IPM Ltd.
11.10.1 Russell IPM Ltd. Company Details
11.10.2 Russell IPM Ltd. Business Overview
11.10.3 Russell IPM Ltd. Biorationals Introduction
11.10.4 Russell IPM Ltd. Revenue in Biorationals Business (2016-2021)
11.10.5 Russell IPM Ltd. Recent Development
11.11 Summit Chemical
11.11.1 Summit Chemical Company Details
11.11.2 Summit Chemical Business Overview
11.11.3 Summit Chemical Biorationals Introduction
11.11.4 Summit Chemical Revenue in Biorationals Business (2016-2021)
11.11.5 Summit Chemical Recent Development
11.12 Suterra
11.12.1 Suterra Company Details
11.12.2 Suterra Business Overview
11.12.3 Suterra Biorationals Introduction
11.12.4 Suterra Revenue in Biorationals Business (2016-2021)
11.12.5 Suterra Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biorationals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Botanical
Table 3. Key Players of Semiochemicals
Table 4. Global Biorationals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biorationals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biorationals Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biorationals Market Share by Regions (2016-2021)
Table 8. Global Biorationals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biorationals Market Share by Regions (2022-2027)
Table 10. Biorationals Market Trends
Table 11. Biorationals Market Drivers
Table 12. Biorationals Market Challenges
Table 13. Biorationals Market Restraints
Table 14. Global Biorationals Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biorationals Market Share by Players (2016-2021)
Table 16. Global Top Biorationals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biorationals as of 2020)
Table 17. Ranking of Global Top Biorationals Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biorationals Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biorationals Product Solution and Service
Table 21. Date of Enter into Biorationals Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biorationals Revenue Market Share by Type (2016-2021)
Table 25. Global Biorationals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biorationals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biorationals Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biorationals Revenue Market Share by Application (2016-2021)
Table 29. Global Biorationals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biorationals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biorationals Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biorationals Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biorationals Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biorationals Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biorationals Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biorationals Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biorationals Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biorationals Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biorationals Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biorationals Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biorationals Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biorationals Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biorationals Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biorationals Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biorationals Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biorationals Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biorationals Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biorationals Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biorationals Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biorationals Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biorationals Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biorationals Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biorationals Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biorationals Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biorationals Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biorationals Market Size by Country (2022-2027) & (US$ Million)
Table 61. Agralan Ltd. Company Details
Table 62. Agralan Ltd. Business Overview
Table 63. Agralan Ltd. Biorationals Product
Table 64. Agralan Ltd. Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 65. Agralan Ltd. Recent Development
Table 66. BASF SE. Company Details
Table 67. BASF SE. Business Overview
Table 68. BASF SE. Biorationals Product
Table 69. BASF SE. Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 70. BASF SE. Recent Development
Table 71. Bayer AG Company Details
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Biorationals Product
Table 74. Bayer AG Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. Gowan Company Company Details
Table 77. Gowan Company Business Overview
Table 78. Gowan Company Biorationals Product
Table 79. Gowan Company Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 80. Gowan Company Recent Development
Table 81. Inora Company Details
Table 82. Inora Business Overview
Table 83. Inora Biorationals Product
Table 84. Inora Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 85. Inora Recent Development
Table 86. Isagro Spa Company Details
Table 87. Isagro Spa Business Overview
Table 88. Isagro Spa Biorationals Product
Table 89. Isagro Spa Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 90. Isagro Spa Recent Development
Table 91. Koppert BV Company Details
Table 92. Koppert BV Business Overview
Table 93. Koppert BV Biorationals Product
Table 94. Koppert BV Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 95. Koppert BV Recent Development
Table 96. McLaughlin Gormley King (MGK) Company Details
Table 97. McLaughlin Gormley King (MGK) Business Overview
Table 98. McLaughlin Gormley King (MGK) Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 99. McLaughlin Gormley King (MGK) Recent Development
Table 100. Rentokil Initial Plc Company Details
Table 101. Rentokil Initial Plc Business Overview
Table 102. Rentokil Initial Plc Biorationals Product
Table 103. Rentokil Initial Plc Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 104. Rentokil Initial Plc Recent Development
Table 105. Russell IPM Ltd. Company Details
Table 106. Russell IPM Ltd. Business Overview
Table 107. Russell IPM Ltd. Biorationals Product
Table 108. Russell IPM Ltd. Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 109. Russell IPM Ltd. Recent Development
Table 110. Summit Chemical Company Details
Table 111. Summit Chemical Business Overview
Table 112. Summit Chemical Biorationals Product
Table 113. Summit Chemical Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 114. Summit Chemical Recent Development
Table 115. Suterra Company Details
Table 116. Suterra Business Overview
Table 117. Suterra Biorationals Product
Table 118. Suterra Revenue in Biorationals Business (2016-2021) & (US$ Million)
Table 119. Suterra Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biorationals Market Share by Type: 2020 VS 2027
Figure 2. Botanical Features
Figure 3. Semiochemicals Features
Figure 4. Global Biorationals Market Share by Application: 2020 VS 2027
Figure 5. Cereals & Grains Case Studies
Figure 6. Fruits & Vegetables Case Studies
Figure 7. Biorationals Report Years Considered
Figure 8. Global Biorationals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Biorationals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Biorationals Market Share by Regions: 2020 VS 2027
Figure 11. Global Biorationals Market Share by Regions (2022-2027)
Figure 12. Global Biorationals Market Share by Players in 2020
Figure 13. Global Top Biorationals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biorationals as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Biorationals Revenue in 2020
Figure 15. Global Biorationals Revenue Market Share by Type (2016-2021)
Figure 16. Global Biorationals Revenue Market Share by Type (2022-2027)
Figure 17. North America Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Biorationals Market Share by Type (2016-2027)
Figure 19. North America Biorationals Market Share by Application (2016-2027)
Figure 20. North America Biorationals Market Share by Country (2016-2027)
Figure 21. United States Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Biorationals Market Share by Type (2016-2027)
Figure 25. Europe Biorationals Market Share by Application (2016-2027)
Figure 26. Europe Biorationals Market Share by Country (2016-2027)
Figure 27. Germany Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Biorationals Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Biorationals Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Biorationals Market Share by Region (2016-2027)
Figure 37. China Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Biorationals Market Share by Type (2016-2027)
Figure 45. Latin America Biorationals Market Share by Application (2016-2027)
Figure 46. Latin America Biorationals Market Share by Country (2016-2027)
Figure 47. Mexico Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Biorationals Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Biorationals Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Biorationals Market Share by Country (2016-2027)
Figure 53. Turkey Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Biorationals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Agralan Ltd. Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 57. BASF SE. Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 58. Bayer AG Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 59. Gowan Company Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 60. Inora Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 61. Isagro Spa Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 62. Koppert BV Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 63. McLaughlin Gormley King (MGK) Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 64. Rentokil Initial Plc Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 65. Russell IPM Ltd. Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 66. Summit Chemical Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 67. Suterra Revenue Growth Rate in Biorationals Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…- 世界の種子・植物育種市場規模・現状・予測（2021年-2027年） Seeds and plant breeding is the science of changing the traits of plants in order to produce desired characteristics. It has been used to improve the quality of nutrition in products for humans and animals. Market Analysis and Insights: Global Seeds and Plant Breeding Market The global Seeds and Pla…
- 世界の種子・植物育種市場規模・現状・予測（2021年-2027年） Seeds and plant breeding is the science of changing the traits of plants in order to produce desired characteristics. It has been used to improve the quality of nutrition in products for humans and animals. Market Analysis and Insights: Global Seeds and Plant Breeding Market The global Seeds and Pla…
- 世界の可変レートテクノロジー（VRT）市場規模・現状・予測（2021年-2027年） Variable-rate technology (VRT) describes any technology which enables producers to vary the rate of crop inputs. VRT combines a variable-rate (VR) control system with application equipment to apply inputs at a precise time and/or location to achieve site-specific application rates of inputs. Market …
- 世界の生物農業市場規模・現状・予測（2021年-2027年） Biological Agriculture manages agriculture in accordance with natural biological processes, properly inputs energy and resources, and maintains the system's optimal productivity. Bio-agriculture emphasizes maintaining land productivity by promoting natural processes and biological cycles, using biol…